[The influence of chemotherapy on delayed allergy in patients with malignant tumors].
D000941:Antigens; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001555:Benzene Derivatives; D001761:Bleomycin / Q000009:adverse effects; D001941:Breast Diseases / Q000188:drug therapy; D001943:Breast Neoplasms / Q000188:drug therapy; D003520:Cyclophosphamide / Q000009:adverse effects; D004338:Drug Combinations; D005260:Female; D005464:Fluorobenzenes; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D006835:Hydrazones / Q000009:adverse effects; D006968:Hypersensitivity, Delayed; D007154:Immune System Diseases / Q000139:chemically induced*; D007111:Immunity, Cellular; D007938:Leukemia / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D008727:Methotrexate / Q000009:adverse effects; D009101:Multiple Myeloma / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology; D009578:Nitrobenzenes; D009848:Olivomycins / Q000009:adverse effects; D012867:Skin / Q000276:immunology; D013274:Stomach Neoplasms / Q000188:drug therapy; D014228:Triaziquone / Q000009:adverse effects; D014373:Tuberculin; D014747:Vinblastine / Q000009:adverse effects
D000941:Antigens; D000970:Antineoplastic Agents; D001555:Benzene Derivatives; D004338:Drug Combinations; D005464:Fluorobenzenes; D006835:Hydrazones; D009578:Nitrobenzenes; D014373:Tuberculin; D001761:Bleomycin; D009848:Olivomycins; D014747:Vinblastine; D003520:Cyclophosphamide; D014228:Triaziquone; D008727:Methotrexate
Vliianie khimiotherapii na zamedlennuiu allergiiu u bol'nykh zlokachestvennymi opukholiami.